Japanese Government Procurement

Sapporo CityA Aflibercept (Genetical Recombination) kit for IVT Injection 40 mg/mL set of 1 kit: approx. 1360 sets B Lenalidomide Hydrate Capsules 5 mg set of 40 capsules: approx. 260 sets C Pembrolizumab (Genetical Recombination) IV Infusion 100 mg/4mL set of 1 vial: approx. 350 sets D Nivolumab (Genetical ...

Japanese

Publishing date Aug 10, 2021
Procurement entity Sapporo City（Hokkaido）
Classification
0004 Medical & Pharmaceutical Products
Summary of notice Summary
(1) Nature and the quantity of the products to be
procured
A Aflibercept (Genetical Recombination) kit
for IVT Injection 40 mg/mL set of 1 kit:
approx. 1360 sets
B Lenalidomide Hydrate Capsules 5 mg set of
40 capsules: approx. 260 sets
C Pembrolizumab (Genetical Recombination) IV
Infusion 100 mg/4mL set of 1 vial: approx.
350 sets
D Nivolumab (Genetical Recombination) IV
Infusion 24 0mg set of 1 vial: approx. 160 sets
E Daratumumab (Genetical Recombination) IV
Infusion 400 mg set of 1 vial: approx. 340 sets
F Ranibizumab (Genetical Recombination) kit
for IVT Injection 10 mg/mL set of 1 kit:
approx. 350 sets
G Ravulizumab (Genetical Recombination) IV
Infusion 300 mg set of 1 vial: approx. 60 sets
H Golimumab (Genetical Recombination)
Autoinjector for SC Injection 50 mg set of
1 autoinjector: approx. 350 sets
I Avelumab (Genetical Recombination) IV
Infusion 200 mg/10mL set of 1 vial: approx.
180 sets
(2) Time limit for tender: 17:00 on September 6
(Mon.), 2021
(3) Contact point for the notice: Management &
Planning Section, Management Department,
Management Office, Hospital Bureau, Sapporo
Municipal Government, Kita 11-jo Nishi 13-
chome, Chuo-ku, Sapporo 060-8604, Japan.TEL
011-726-2211